Related Experiment Video
Updated: Apr 19, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Integrating omics: the future of IBD?
1Department of Gastroenterology and Hepatology, Digestive Disease Institute, and Department of Pathobiology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Inflammatory Bowel Disease (IBD) arises from complex interactions between the exposome, genome, microbiome, and immunome. Omics technologies offer new tools to understand these interactions and develop personalized medicine for IBD patients.
Area of Science:
- Gastroenterology and Molecular Biology
- Focus on complex diseases and personalized medicine
Background:
- Inflammatory Bowel Disease (IBD) pathogenesis involves four key components: environment (exposome), genetics (genome), gut microbiota (microbiome), and mucosal immune response (immunome).
- These factors interact intricately, forming an 'IBD interactome' or 'integrome', rather than a single cause driving disease development.
Purpose of the Study:
- To highlight the complexity of IBD pathogenesis and the need for advanced approaches.
- To introduce 'omics' technologies as essential tools for understanding the 'IBD integrome'.
Main Methods:
- Utilizing 'omics' approaches (genomics, transcriptomics, proteomics, metabolomics) to comprehensively study biological molecules.
- Employing bioinformatics tools to analyze vast datasets from 'omics' analyses and identify molecular interactions.
Main Results:
- Demonstrates the applicability of omics technologies to unravel the complex interactions in IBD.
- Identifies the potential of omics-based approaches for personalized medicine in IBD.
Conclusions:
- Omics technologies and bioinformatics are crucial for understanding the IBD integrome.
- Implementing omics-based healthcare is essential for advancing personalized medicine and improving therapies for Crohn's disease and ulcerative colitis patients.
Related Concept Videos
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

